atezolizumab,cabozantinib
exelixis,roche
['urothelial', 'atezo', 'cosmic-021', 'cabozantinib']
#asco22 news: fresh data from cosmic-021 point to the promise of cabozantinib atezolizumab in untreated &amp; ici-treated advanced urothelial cancer. here's our report of the presentation by &amp; discussion by 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.